This announcement is a separate document:
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director van Es-Johansson An
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.